MarketPeel
Insider Trading Intelligence
HK

Holly B. Kordasiewicz

IONS
EVP, CHIEF DEVELOPMENT OFFICER · IONIS PHARMACEUTICALS INC · CIK 0002102721
FILING MIX · LIFETIME53%/47%
BUYS
9
SELLS
8
TOTAL VALUE
$8.06M
COMPANIES
1
ACTIVE SINCE
Jan 2026
HOLDINGS NOW
51,409
AVG SELL PX
$73.55
TRADE KIND
SHOWING 17 / 17
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 3 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Holly B. Kordasiewicz, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+0.00%+5.19%-0.35%+5.54%+5.54%
14d1+0.00%+8.31%+0.04%+8.26%+8.26%
30d1+0.00%+5.59%-1.43%+7.03%+7.03%
60d1+100.00%-5.24%-3.02%-2.22%-2.22%
90d1+100.00%-1.40%+1.45%-2.85%-2.85%
180d1(1 pending)
1y1(1 pending)
2y1(1 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
IONS · 51,409 shares · as of Jun 12, 2026
020,82641,65262,47883,304SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2026
2026
FLOW · 9 buys / 8 sellsCOVERAGE · 2 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chief Development Officer
21,0000Jun 12, 2026Jun 16, 2026View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
EVP, Chief Development Officer
19,895$56.78$1.13M83,304Jun 12, 2026Jun 16, 2026View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chief Development Officer
19,8950Jun 12, 2026Jun 16, 2026View →
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
19,842$74.05$1.47M22,458Jun 12, 2026Jun 16, 2026View →
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
41,004$73.09$3.00M42,300Jun 12, 2026Jun 16, 2026View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
EVP, Chief Development Officer
7,951$60.89$484.1K30,409Jun 12, 2026Jun 16, 2026View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
EVP, Chief Development Officer
12,000$32.60$391.2K63,409Jun 12, 2026Jun 16, 2026View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chief Development Officer
7,95121,000Jun 12, 2026Jun 16, 2026View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chief Development Officer
12,0000Jun 12, 2026Jun 16, 2026View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
EVP, Chief Development Officer
21,000$60.89$1.28M51,409Jun 12, 2026Jun 16, 2026View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chief Development Officer
4,141$75.66$313.3K14,718Jan 16, 2026Jan 20, 2026View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
11,25045,730Jan 15, 2026Jan 20, 2026View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
EVP, Chief Development Officer
11,11918,859Jan 15, 2026Jan 20, 2026View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chief Development Officer
11,11920,830Jan 15, 2026Jan 20, 2026View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
13,65034,480Jan 15, 2026Jan 20, 2026View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
9,1009,100Jan 2, 2026Jan 5, 2026View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
7,50016,600Jan 2, 2026Jan 20, 2026View →
Other insiders · IONS
Loading peer insiders…
About this filer
CIK 0002102721
ROLE
EVP, Chief Development Officer
PRIMARY
IONS
COMPANIES
1
ACTIVE SINCE
Jan 2026
MARKETPEEL · /INSIDER/0002102721DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback